Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRACAMERALStandard

IDOSE TR

TRAVOPROST

Standard Dose
75MCG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview IDOSE TR is listed in Drugs@FDA under application 218010 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient TRAVOPROST Form and strength IMPLANT;INTRACAMERAL - 75MCG Sponsor GLAUKOS Submission history Latest submission status date: 2026-01-27 00:00:00.

Structured Monograph

Clinical summary

Approval overview IDOSE TR is listed in Drugs@FDA under application 218010 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient TRAVOPROST Form and strength IMPLANT;INTRACAMERAL - 75MCG Sponsor GLAUKOS Submission history Latest submission status date: 2026-01-27 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
IDOSE TR (TRAVOPROST) | Drug Monograph | MedicHelpline